Christine Lair

Targeting DnaN for tuberculosis therapy using novel griselimycins

Angela Kling, Peer Lukat, Deepak V. Almeida et al. · Science · 2015 · 313 citations

Life Sciences, Biotechnology, Molecular Biology +16

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization

Danielle Gully, Michel Geslin, Laurence Serva et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 75 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Effects of Divalent Cations and of a Calcimimetic on Adrenocorticotropic Hormone Release in Pituitary Tumor Cells

Sandrine Ferry, Bruno Chatel, Robert H. Dodd et al. · Biochemical and Biophysical Research Communications · 1997 · 42 citations

Medicine, Biochemistry, Endocrinology +16

Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents

Jidong Zhang, Christine Lair, Kwame Amaning et al. · Cell · 2023 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Identification and optimization of a new series of anti-tubercular quinazolinones

Cédric Couturier, Christine Lair, Alain Pellet et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 21 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7